Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer

Danson, S., Ferry, D., Alakhov, V. et al. (6 more authors) (2004) Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer. British Journal of Cancer, 90 (11). pp. 2085-2091. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Danson, S.
  • Ferry, D.
  • Alakhov, V.
  • Margison, J.
  • Kerr, D.
  • Jowle, D.
  • Brampton, M.
  • Halbert, G.
  • Ranson, M.
Copyright, Publisher and Additional Information: © Year The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike Licence (https://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
Keywords: SP1049C; doxorubicin; polymer; pharmacokinetics; phase I
Dates:
  • Published: 26 May 2004
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 22 Nov 2016 14:37
Last Modified: 22 Nov 2016 14:40
Published Version: http://dx.doi.org/10.1038/sj.bjc.6601856
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6601856

Share / Export

Statistics